相关实验视频
Updated: Jan 8, 2026

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
967
在风湿性关节炎中探索间歇性肺部疾病的抗纤维化策略:叙述性综述
Narjes Sadat Farizani Gohari1, Farahnaz Hoseinzadeh2, Amirmohammad Khalaji3
1International Campus, Shahid Sadoughi University of Medical Science, Yazd, Iran.
Open access rheumatology : research and reviews
|December 18, 2025
概括
类风湿性关节炎 (RA) 可以导致肺纤维化,类似于异常性肺纤维化 (IPF). 对IPF有效的抗纤维素药物可以治疗RA相关的肺部疾病,但需要更多的研究.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 类风湿性关节炎 (RA) 是一种自身免疫性疾病,具有潜在的关节外表现,包括间歇性肺病 (ILD).
- 常见的间歇性肺炎和非特异性间歇性肺炎是RA常见的ILD,导致肺纤维化和更差的预后.
- 在RA中驱动ILD的确切机制尚未完全理解,但涉及环境,遗传和免疫因素.
研究的目的:
- 为了比较风湿性关节炎 (RA) 中纤维化肺病的发展与异常性肺纤维化 (IPF).
- 探索抗纤维素剂在治疗与RA相关的纤维素性ILD中的潜力.
主要方法:
- 在RA和IPF中对肺纤维化过程的比较分析.
- 审查现有的关于ILD在RA和抗纤维素治疗的文献.
主要成果:
- 在RA-ILD和IPF之间的病原和炎症途径的相似性表明肺纤维化有共同的潜在机制.
- 目前的RA治疗在治疗渐进性肺纤维化方面效果有限.
结论:
- 在IPF治疗中成功的抗纤维素药物代表了对RA纤维化肺部变化的有前途的治疗策略.
- 进一步的大规模临床试验对于验证RA-ILD抗纤维素药物的有效性和安全性至关重要.
相关概念视频
Rheumatic Heart Disease III: Medical Management
264
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
264
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Rheumatic Heart Disease IV: Nursing Management
247
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
247
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
879
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
879
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
COPD: Management Using Bronchodilators and Corticosteroids
700
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
700

